|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Knight SB, Crosbie PA, Balata H, Chudziak
J, Hussell T and Dive C: Progress and prospects of early detection
in lung cancer. Open Biol. 7(pii): 1700702017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang JT, Lee YM and Huang RS: The impact
of the cancer genome atlas on lung cancer. Transl Res. 166:568–585.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martin P and Leighl NB: Review of the use
of pretest probability for molecular testing in non-small cell lung
cancer and overview of new mutations that may affect clinical
practice. Ther Adv Med Oncol. 9:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R,
Wu J, Feng J and Chen P: LncRNA HOXA11-AS drives cisplatin
resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Cancer Sci. 109:3068–3079. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gan TQ, Chen WJ, Qin H, Huang SN, Yang LH,
Fang YY, Pan LJ, Li ZY and Chen G: Clinical value and prospective
pathway signaling of MicroRNA-375 in lung adenocarcinoma: A study
based on the cancer genome atlas (TCGA), gene expression omnibus
(GEO) and bioinformatics analysis. Med Sci Monit. 23:2453–2464.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi YX, Zhu T, Zou T, Zhuo W, Chen YX,
Huang MS, Zheng W, Wang CJ, Li X, Mao XY, et al: Prognostic and
predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Oncotarget. 7:85235–85243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shang J, Song Q, Yang Z, Li D, Chen W, Luo
L, Wang Y, Yang J and Li S: Identification of lung adenocarcinoma
specific dysregulated genes with diagnostic and prognostic value
across 27 TCGA cancer types. Oncotarget. 8:87292–87306. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kober KM, Olshen A, Conley YP, Schumacher
M, Topp K, Smoot B, Mazor M, Chesney M, Hammer M, Paul SM, et al:
Expression of mitochondrial dysfunction-related genes and pathways
in paclitaxel-induced peripheral neuropathy in breast cancer
survivors. Mol Pain. 14:17448069188164622018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Aarag SA, Mahmoud A, Hashem MH, Abd
Elkader H, Hemeida AE and ElHefnawi M: In silico identification of
potential key regulatory factors in smoking-induced lung cancer.
BMC Med Genomics. 10:402017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan L, Yu X, Huang Z, Zheng S, Zhou Y, Lv
H, Zeng Y, Xu JF, Zhu X and Yi X: Analysis of Microarray-identified
genes and microRNAs associated with idiopathic pulmonary fibrosis.
Mediators Inflamm. 2017:18042402017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Liu X, Liu T, Meng X, Yin X, Fang C,
Huang D, Cao Y, Weng H, Zeng X and Wang X: Identification of
biomarkers correlated with the TNM staging and overall survival of
patients with bladder cancer. Front Physiol. 8:9472017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kadara H, Choi M, Zhang J, Parra ER,
Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J,
Chow C, et al: Whole-exome sequencing and immune profiling of
early-stage lung adenocarcinoma with fully annotated clinical
follow-up. Ann Oncol. 29:1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu TP, Lee JM, Hsu CP, et al: Genome-wide
screening of genomic alterations and transcriptional modulation in
non-smoking female lung cancer in Taiwan. Cancer Res. 69:2009.
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy - analysis of affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Langfelder P, Zhang B and Horvath S:
Defining clusters from a hierarchical cluster tree: The Dynamic
Tree Cut package for R. Bioinformatics. 24:719–720. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang J, Kong D, Cui Q, Wang K, Zhang D,
Gong Y and Wu G: Prognostic genes of breast cancer identified by
gene co-expression network analysis. Fron Oncol. 8:4742018.
|
|
19
|
Zhang Y, Foreman O, Wigle DA, Kosari F,
Vasmatzis G, Salisbury JL, van Deursen J and Galardy PJ: USP44
regulates centrosome positioning to prevent aneuploidy and suppress
tumorigenesis. J Clin Invest. 122:4362–4374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robinson DR, Wu YM, Lonigro RJ, Vats P,
Cobain E, Everett J, Cao X, Rabban E, Kumar-Sinha C, Raymond V, et
al: Integrative clinical genomics of metastatic cancer. Nature.
548:297–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oronsky B, Reid TR, Oronsky A and Carter
CA: What's new in SCLC? A review. Neoplasia. 19:842–847. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JW, Ryu YK, Ji YH, Kang JH and Moon
EY: Hypoxia/reoxygenation-experienced cancer cell migration and
metastasis are regulated by Rap1-and Rac1-GTPase activation via the
expression of thymosin beta-4. Oncotarget. 6:9820–9833.
2015.PubMed/NCBI
|
|
25
|
Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang
K, Go MY, Ng SC, Chan FK, Sung JJ and Yu J: Carbonic anhydrase IV
inhibits colon cancer development by inhibiting the Wnt signalling
pathway through targeting the WTAP-WT1-TBL1 axis. Gut.
65:1482–1493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan TL, Wang PW, Huang CC, Yeh CT, Hu TH
and Yu JS: Network analysis and proteomic identification of
vimentin as a key regulator associated with invasion and metastasis
in human hepatocellular carcinoma cells. J Proteomics.
75:4676–4692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Waheed A and Sly WS: Membrane associated
carbonic anhydrase IV (CA IV): A personal and historical
perspective. Subcell Biochem. 75:157–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen J, Hu L, Zhang F, Wang J, Chen J and
Wang Y: Downregulation of carbonic anhydrase IV contributes to
promotion of cell proliferation and is associated with poor
prognosis in non-small cell lung cancer. Oncol Lett. 14:5046–5050.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Villar J, Zhang H and Slutsky AS: Lung
repair and regeneration in acute respiratory distress syndrome:
Role of PECAM1 and Wnt signaling. Chest. 155:587–594. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren Q, Ren L, Ren C, Liu X, Dong C and
Zhang X: Platelet endothelial cell adhesion molecule-1 (PECAM1)
plays a critical role in the maintenance of human vascular
endothelial barrier function. Cell Biochem Funct. 33:560–565. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen CH, Chang WH, Su KY, Ku WH, Chang GC,
Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, et al: HLJ1 is an
endogenous Src inhibitor suppressing cancer progression through
dual mechanisms. Oncogene. 35:5674–5685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Riehl A, Nemeth J, Angel P and Hess J: The
receptor RAGE: Bridging inflammation and cancer. Cell Commun
Signal. 7:122009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sparvero LJ, Asafu-Adjei D, Kang R, Tang
D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, et al:
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands,
and their role in cancer and inflammation. J Transl Med. 7:172009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pan Z, Liu L, Nie W, Miggin S, Qiu F, Cao
Y, Chen J, Yang B, Zhou Y, Lu J and Yang L: Long non-coding RNA
AGER-1 functionally upregulates the innate immunity gene AGER and
approximates its anti-tumor effect in lung cancer. Mol Carcinog.
57:305–318. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ho CH and Tsai SF: Functional and
biochemical characterization of a T cell-associated anti-apoptotic
protein, GIMAP6. J Biol Chem. 292:9305–9319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pascall JC, Rotondo S, Mukadam AS, Oxley
D, Webster J, Walker SA, Piron J, Carter C, Ktistakis NT and
Butcher GW: The immune system GTPase GIMAP6 interacts with the Atg8
homologue GABARAPL2 and is recruited to autophagosomes. PLoS One.
8:e777822013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Rubinstein R, Lines JL, Wasiuk A,
Ahonen C, Guo Y, Lu LF, Gondek D, Wang Y, Fava RA, et al: VISTA, a
novel mouse Ig superfamily ligand that negatively regulates T cell
responses. J Exp Med. 208:577–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Flies DB, Wang S, Xu H and Chen L: Cutting
edge: A monoclonal antibody specific for the programmed death-1
homolog prevents graft-versus-host disease in mouse models. J
Immunol. 187:1537–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie S, Huang J, Qiao Q, Zang W, Hong S,
Tan H, Dong C, Yang Z and Ni L: Expression of the inhibitory B7
family molecule VISTA in human colorectal carcinoma tumors. Cancer
Immunol Immunother. 67:1685–1694. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu J-R, Tai Y, Jin Y, Hammell MC,
Wilkinson JE, Roe J-S, Vakoc CR and Van Aelst L: TGF-β/Smad
signaling through DOCK4 facilitates lung adenocarcinoma metastasis.
Genes Dev. 29:250–261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Westbrook JA, Wood SL, Cairns DA, McMahon
K, Gahlaut R, Thygesen H, Shires M, Roberts S, Marshall H, Oliva
MR, et al: Identification and validation of DOCK4 as a potential
biomarker for risk of bone metastasis development in patients with
early breast cancer. J Pathol. 247:381–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Debruyne DN, Turchi L, Burel-Vandenbos F,
Fareh M, Almairac F, Virolle V, Figarella-Branger D, Baeza-Kallee
N, Lagadec P, Kubiniek V, et al: DOCK4 promotes loss of
proliferation in glioblastoma progenitor cells through nuclear
beta-catenin accumulation and subsequent miR-302-367 cluster
expression. Oncogene. 37:241–254. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Donizy P, Kaczorowski M, Biecek P, Halon
A, Szkudlarek T and Matkowski R: Golgi-related proteins GOLPH2
(GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in cutaneous melanoma:
Patterns of expression and prognostic significance. Int J Mol Sci.
17(pii): E16192016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu L, Li L, Xie H, Gu Y and Peng T: The
Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the
transmembrane and cytoplamic sequences. PLoS One. 6:e282072011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Arun a and Li LM: Overexpression of golgi
membrane protein 1 promotes non-small-cell carcinoma aggressiveness
by regulating the matrix metallopeptidase 13. Am J Cancer Res.
8:551–565. 2018.PubMed/NCBI
|
|
47
|
McIntyre TM, Prescott SM and Stafforini
DM: The emerging roles of PAF acetylhydrolase. J Lipid Res.
(Suppl):50:S255–S259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bonin F, Ryan SD, Migahed L, Mo F, Lallier
J, Franks DJ, Arai H and Bennett SAL: Anti-apoptotic actions of the
platelet-activating factor acetylhydrolase I alpha2 catalytic
subunit. J Biol Chem. 279:52425–52436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mulvihill MM, Benjamin DI, Ji X, Le Scolan
E, Louie SM, Shieh A, Green M, Narasimhalu T, Morris PJ, Luo K and
Nomura DK: Metabolic profiling reveals PAFAH1B3 as a critical
driver of breast cancer pathogenicity. Chem Biol. 21:831–840. 2014.
View Article : Google Scholar : PubMed/NCBI
|
